dos Santos, Julia Matzenbacher
Joiakim, Aby
Putt, David A.
Scherrer-Crosbie, Marielle
Kim, Hyesook
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (N261201600028C)
Article History
Received: 27 July 2023
Accepted: 4 December 2023
First Online: 15 December 2023
Declarations
:
: Institutional Review Board (IRB) Statement: Coded plasma samples from HER2-positive breast cancer patients approved by the Institutional Review Board (IRB) were provided by Dr. Scherrer-Crosbie from Massachusetts General Hospital and Harvard Medical School (Boston, MA). This is a secondary use for the specimens. Use of the coded plasma samples for this study (NHLBI SBIR contract N261201600028C) was determined by the Wayne State University (Detroit, MI) Human Participant Research (HPR) Determination (#2016 78).Animal Study: Use of animals for this study was approved by the Institutional Animal Care and Use Committee (IACUC), Wayne State University, Detroit Michigan: Protocol ID, 16–05-086, Principal Investigator, Hyesook Kim.
: M. S.-C. declares that she has no competing interests. H. K. is the president of Detroit R&D, Inc. and A. J. and D. A. P. work for Detroit R&D, Inc. J.M.S worked at Detroit R&D, Inc and collaborates with the company.